Carol DePriest

Intracavitary Placement of Autologous Lymphokine-Activated Killer (LAK) Cells after Resection of Recurrent Glioblastoma

Robert O. Dillman, Christopher Duma, Patric M. Schiltz et al. · Journal of Immunotherapy · 2004 · 117 citations

Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy

Robert O. Dillman, Andrew N. Cornforth, Carol DePriest et al. · Journal of Immunotherapy · 2012 · 74 citations

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Robert O. Dillman, Andrew N. Cornforth, Gabriel I. Nistor et al. · Journal for ImmunoTherapy of Cancer · 2018 · 71 citations · Full text

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz et al. · Cancer Biotherapy and Radiopharmaceuticals · 2009 · 67 citations

Interferon-Gamma or Granulocyte-Macrophage Colony-Stimulating Factor Administered as Adjuvants With a Vaccine of Irradiated Autologous Tumor Cells From Short-Term Cell Line Cultures: A Randomized Phase 2 Trial of the Cancer Biotherapy Research Group

Robert O. Dillman, Michael C. Wiemann, Shankar K. Nayak et al. · Journal of Immunotherapy · 2003 · 58 citations

Short-term Cell Line, Immunology, Immunoediting +18